CHOLINERGIC POTENTIATION OF BINOCULAR VISION
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Oct 13, 2022
app pub date -
Aug 12, 2020
filing date -
Aug 13, 2019
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
The present disclosure concerns the use of a cholinesterase inhibitor for improving binocular function and, in some embodiments, lessening an imbalance of binocular vision by promoting fusional ability and/or reducing interocular inhibition in a subject. The cholinesterase inhibitor canbe used to treat or alleviate the symptoms of amblyopia or diplopia. The cholinesterase inhibitor can be a specific and reversible acetylcholinesterase inhibitor, such as, for example, donepezil (also referred to as donepezil or Aricept®).
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully